What Fresenius appoints Mahl means for Fresenius stock

Published on 10/17/2026 at 10:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock last closed at EUR 45.08 on Xetra on October 16, 2026. The board appointed Mahl and extended the CFO contract through 2032.

Key dates and closing level

Fresenius appointed Dr. Marc-Alexander Mahl to its Management Board on October 15, 2026.
Fresenius stock last closed at EUR 45.08 on Xetra on October 16, 2026.
Fresenius is scheduled to publish its quarterly financial report on November 4, 2026.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht — Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

On October 15, 2026, Fresenius appointed Dr. Marc-Alexander Mahl to its Management Board and extended Chief Financial Officer Sara Hennicken’s contract for another five years, through 2032, according to EQS News.

Market context: Market report DAX.

The week in figures

Fresenius closed at EUR 45.08 on Xetra on October 16, 2026. The listed issuer is Fresenius SE & Co. KGaA, traded under the Xetra symbol FRE.

The next price is shown from the start of trading by the continuously updated real-time quote of Fresenius stock.

Chronology of the week

On October 15, 2026, the Supervisory Board appointed Mahl effective November 1, 2026. He will be responsible for the Fresenius Kabi businesses and will succeed Pierluigi Antonelli, who is leaving the company for personal reasons. The board also assigned overall responsibility for Nutrition to Sébastien Guery. The announcement was distributed by EQS News.